FindTrial
Sign In

Efficacy and safety of CT-guided thoracic sympathetic nerve ablation in the treatment of primary craniofacial hyperhidrosis

Efficacy and safety of CT-guided thoracic sympathetic nerve ablation in the treatment of primary craniofacial hyperhidrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045150
Enrollment
Unknown
Registered
2021-04-07
Start date
2021-04-30
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary craniofacial hyperhidrosis

Interventions

Group radiofrequency ablation of thoracic sympathetic nerve guided by CT:no

Sponsors

The Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 66 Years

Inclusion criteria

Inclusion criteria: 1.Clinical diagnosis of primary scalp sweating; 2.The drug treatment is invalid; 3.Onset age 25 years old; 4.ASA classification are grade I-II.

Exclusion criteria

Exclusion criteria: 1.Plantar and axillary hyperhidrosis, no scalp sweating; 2.Is participating in it; The patient (subject) of its clinical trial; 3.Researchers think other reasons are not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
Complete remission rate of postoperative head sweating;—

Countries

china

Contacts

Public ContactTang Jing

The Affiliated Hospital of Guangdong Medical University

tanglitangjing@126.com+86 13189091282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026